X-2934665-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000047.3(ARSL):c.*167T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00608 in 423,803 control chromosomes in the GnomAD database, including 47 homozygotes. There are 618 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.017 ( 38 hom., 441 hem., cov: 22)
Exomes 𝑓: 0.0024 ( 9 hom. 177 hem. )
Consequence
ARSL
NM_000047.3 3_prime_UTR
NM_000047.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.62
Genes affected
ARSL (HGNC:719): (arylsulfatase L) Arylsulfatase E is a member of the sulfatase family. It is glycosylated postranslationally and localized to the golgi apparatus. Sulfatases are essential for the correct composition of bone and cartilage matrix. X-linked chondrodysplasia punctata, a disease characterized by abnormalities in cartilage and bone development, has been linked to mutations in this gene. Alternative splicing results in multiple transcript variants. A pseudogene related to this gene is located on the Y chromosome. [provided by RefSeq, Sep 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant X-2934665-A-G is Benign according to our data. Variant chrX-2934665-A-G is described in ClinVar as [Benign]. Clinvar id is 1272237.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0544 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSL | NM_000047.3 | c.*167T>C | 3_prime_UTR_variant | 11/11 | ENST00000381134.9 | NP_000038.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSL | ENST00000381134 | c.*167T>C | 3_prime_UTR_variant | 11/11 | 1 | NM_000047.3 | ENSP00000370526.3 |
Frequencies
GnomAD3 genomes AF: 0.0166 AC: 1827AN: 109787Hom.: 38 Cov.: 22 AF XY: 0.0138 AC XY: 442AN XY: 32117
GnomAD3 genomes
AF:
AC:
1827
AN:
109787
Hom.:
Cov.:
22
AF XY:
AC XY:
442
AN XY:
32117
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00239 AC: 750AN: 313968Hom.: 9 Cov.: 4 AF XY: 0.00182 AC XY: 177AN XY: 97330
GnomAD4 exome
AF:
AC:
750
AN:
313968
Hom.:
Cov.:
4
AF XY:
AC XY:
177
AN XY:
97330
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0166 AC: 1828AN: 109835Hom.: 38 Cov.: 22 AF XY: 0.0137 AC XY: 441AN XY: 32175
GnomAD4 genome
AF:
AC:
1828
AN:
109835
Hom.:
Cov.:
22
AF XY:
AC XY:
441
AN XY:
32175
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 26, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at